Hyphens Pharma International Limited is Singapore’s leading specialty pharmaceutical and consumer healthcare group. 

It develops and owns several dermatological products and supplements, such as Ceradan, TDF and Ocean Health. 

The Group also markets and sells specialty pharmaceutical products through exclusive agreements, as well as operates an online B2B platform for healthcare professionals. 

Please visit us at https://www.hyphensgroup.com for more information.

FY2021 Earnings Presentation

FY2020 Earnings Presentation

Join Mr. Lim See Wah, Chairman and CEO of @Hyphens Pharma International Limited on 7 June (Tuesday), 5pm SGT as he speaks to Smartkarma Analyst, Tina Banerjee, on our businesses. He will share a brief company presentation, after which he will engage in a fireside chat and a live Q&A. Save your spot today! Register here: http://bit.ly/junwebinar

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Hyphens Pharma International (HYP SP)

FY2021 Earnings Presentation

FY2020 Earnings Presentation

Hyphens Pharma: 5 Reasons to Own

1Q2020 Earnings Presentation

FY2019 Earnings Presentation

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)